Share on StockTwits

Alexza Pharmaceuticals (NASDAQ:ALXA) posted its quarterly earnings results on Thursday. The company reported ($0.34) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.67) by $0.33, Analyst Ratings Network.com reports. The company had revenue of $1.50 million for the quarter, compared to the consensus estimate of $2.24 million.

Alexza Pharmaceuticals (NASDAQ:ALXA) traded up 2.97% during mid-day trading on Thursday, hitting $4.86. The stock had a trading volume of 70,890 shares. Alexza Pharmaceuticals has a 52 week low of $3.92 and a 52 week high of $5.93. The stock has a 50-day moving average of $4.70 and a 200-day moving average of $4.69. The company’s market cap is $84.2 million.

Alexza Pharmaceuticals, Inc (NASDAQ:ALXA) is a pharmaceutical company focused on the research, development, and commercialization of products for the acute treatment of central nervous system (CNS) conditions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.